Pacific Biosciences (PACB)
1.2050 -0.0750 (-5.86%) 13:00 ET [NASDAQ]
1.2000 x 6397 1.2100 x 7050
Realtime by (Cboe BZX)
1.2000 x 6397 1.2100 x 7050
Realtime 1.3000 +0.0200 (+1.56%) 09:29 ET
for Thu, Mar 13th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -306,735 | -314,248 | -181,223 | 29,403 | -84,134 |
| Depreciation Amortization | 13,694 | 17,074 | 15,596 | 9,326 | 10,247 |
| Income taxes - deferred | -11,424 | N/A | -93,649 | N/A | 0 |
| Accounts receivable | -17,829 | 5,455 | -7,166 | -1,603 | -6,671 |
| Accounts payable and accrued liabilities | 206 | 1,025 | 6,363 | -5,072 | 1,713 |
| Other Working Capital | -58,957 | -53,972 | 20,327 | -3,286 | -3,004 |
| Other Operating Activity | 121,872 | 81,455 | 128,572 | -9,265 | 3,537 |
| Operating Cash Flow | $-259,173 | $-263,211 | $-111,180 | $19,503 | $-78,312 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,549 | 133,012 | -352,807 | -218,283 | 64,883 |
| PPE Investments | -8,843 | -16,750 | -5,931 | -1,039 | -2,836 |
| Net Acquisitions | -102 | N/A | -319,793 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -179 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -179 | 0 | 0 | 0 |
| Investing Cash Flow | $4,604 | $116,083 | $-678,531 | $-219,322 | $62,047 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 895,536 | N/A | N/A |
| Debt Repayment | -1,842 | -1,608 | -361 | -16,000 | N/A |
| Common Stock Issued | 204,519 | 11,230 | 326,651 | 233,839 | 8,548 |
| Other Financing Activity | -93,786 | 0 | -52,245 | 34,000 | 18,000 |
| Financing Cash Flow | $108,891 | $9,622 | $1,169,581 | $251,839 | $26,548 |
| Beginning Cash Position | 328,311 | 465,817 | 85,947 | 33,927 | 23,644 |
| End Cash Position | 182,633 | 328,311 | 465,817 | 85,947 | 33,927 |
| Net Cash Flow | $-145,678 | $-137,506 | $379,870 | $52,020 | $10,283 |
| Free Cash Flow | |||||
| Operating Cash Flow | -259,173 | -263,211 | -111,180 | 19,503 | -78,312 |
| Capital Expenditure | -8,843 | -16,750 | -5,931 | -1,039 | -2,836 |
| Free Cash Flow | -268,016 | -279,961 | -117,111 | 18,464 | -81,148 |